Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Jan;2(1):e3.
doi: 10.1371/journal.pmed.0020003.

Intermittent presumptive treatment for malaria

Affiliations
Review

Intermittent presumptive treatment for malaria

Nicholas J White. PLoS Med. 2005 Jan.

Abstract

A better understanding of the pharmacodynamics of intermittent presumptive treatment, says White, will guide more rational policymaking

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The author is on the editorial board of PLoS Medicine.

Figures

Figure 1
Figure 1. In Vivo Antimalarial Pharmacodynamics
The parasite burden in an adult (vertical axis) is shown in green. After parasite burden expands to the point where it causes illness, treatment is given (red arrow), which causes a log-linear decline in parasite numbers until concentrations of the antimalarial drug (grey shading) fall below the MPC. As the antimalarial blood levels fall further, the decline in parasite burden slows until it reaches a multiplication rate of one (the antimalarial concentration at this point is the in vivo MIC). The parasite population then expands to cause a recrudescence six weeks later. The sigmoid concentration–effect relationship is shown in brown; it is depicted in the reverse direction to that normally drawn. PMR, parasite multiplication rate.
Figure 2
Figure 2. Blood Concentration Profiles of Two Antimalarials with Different Elimination Profiles
The examples shown here are mefloquine (orange) and chloroquine (pink). An increase in MIC has different effects on the shortening of post-treatment suppressive prophylaxis (hatched bars). MICR, MIC for resistant parasites; MICS, MIC for sensitive parasites.
Figure 3
Figure 3. Hypothetical Parasite Burden Profiles during Pregnancy with SP IPT in a High-Transmission Setting
Entomological inoculation rate is about 50 infectious bites per person per year. Note that many infections self-cure (each infection is depicted as a green line). The hatched bars represent the duration of “suppressive prophylactic activity”, and the solid bars represent the period during which parasite multiplication is suppressed (i.e., levels exceed the in vivo MIC). The horizontal dotted line at 108 parasites represents the level at which malaria can be detected on a blood film. (A) represents a drug-sensitive area; (B) represents a moderately resistant area.
Figure 4
Figure 4. Relationship between MIC and PTP
The proportional increase in malaria parasite MIC with resistance is plotted against the shortening of the duration of PTP, expressed as multiples of the terminal half-life. This applies only to drugs for which suppressive antimalarial prophylaxis occurs in the terminal elimination phase (i.e., most drugs).

Similar articles

Cited by

References

    1. Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L, et al. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg. 1994;51:515–522. - PubMed
    1. Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Russell WB, et al. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Ann Trop Med Parasitol. 1998;92:141–150. - PubMed
    1. Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg. 1998;59:813–822. - PubMed
    1. Shulman CE, Dorman EK, Cutts F, Kawuondo K, Bulmer JN, et al. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: A randomised placebo-controlled trial. Lancet. 1999;353:632–636. - PubMed
    1. Njagi JK, Magnussen P, Estambale B, Ouma J, Mugo B. Prevention of anaemia in pregnancy using insecticide-treated bednets and sulfadoxine-pyrimethamine in a highly malarious area of Kenya: A randomized controlled trial. Trans R Soc Trop Med Hyg. 2003;97:277–282. - PubMed